MUMBAI (Reuters) - India's largest drugmaker Sun Pharmaceutical Industries Ltd's shares opened down 6.4 percent on Monday, after the U.S. Food and Drug Administration issued the firm a warning letter on its key Halol manufacturing plant in western India.
http://ift.tt/xePdMM
from Reuters: Health News
via animenewspro
Aucun commentaire:
Enregistrer un commentaire